CompletedPHASE2, PHASE3NCT04380519

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: R-Pharm International, LLC
Principal Investigator: Mikhail Samsonov
Chief Medical Officer, R-Pharm
Intervention: RPH-104 80 mg(drug)
Enrollment: 372 enrolled
Eligibility: 18 years · All sexes
Timeline: 2020 – 2020

Study locations (16)

Private healthcare institution "Clinical Hospital" Russian Railways-Medicine named after N. A. Semashko", Moscow, Russia
State Budget Healthcare Institution "City Clinical Hospital № 15 named after O.M. Filatov" of Moscow City Healthcare Department, Moscow, Russia
Federal State Budgetary Institution "Federal Center for Cerebrovascular Pathology and Stroke" of the Ministry of Health of the Russian Federation, Moscow, Russia
Federal State Autonomous Education Insitution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of Russian Federation (Sechenov University), Moscow, Russia
Federal State Autonomous Education Institution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of the Russian Federation (Sechenov University), Moscow, Russia
Federal State Budgetary Institution "Central Clinical Hospital with Polyclinic" of Administrative Directorate of the President of the Russian Federation, Moscow, Russia
Federal State Budget Institution "National Medicine Research Center on Cardiology" By Ministry of Healthcare of Russian Federation, Moscow, Russia
State Budget Institution of Healthcare "City Clinical Hospital #52", Moscow City Healthcare Department, Moscow, Russia
State budgetary healthcare institution City Clinical Hospital named after S.I. Spasokukotsky Department of Health of the city of Moscow City Clinical Hospital No. 50, Moscow, Russia
Moscow State Budget Institution of Healthcare "Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare", Moscow, Russia
АО "State Company "Medsi" based on Clinical Hospital №1", Moscow, Russia
Federal State Budgetary Educational Institution of Higher Education "Volga Research Medical University" of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia
Federal Budgetary State Healthcare Institution "National Medical Research Center named after B.A. Almazov", Saint Petersburg, Russia
Saint-Petersburg State Budget Institution of Healthcare "City Hospital №40", Saint Petersburg, Russia
Budgetary Health Institution Voronezh Regional Clinical Hospital №1, Voronezh, Russia
+1 more locations on ClinicalTrials.gov

Collaborators

Data Management 365 · K-Research, LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04380519 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome →

← Back to all trials